[Go to site: main page, start]
Future Funds

Future Funds

Home
Notes
Chat
Archive
About
Global scale of rare diseases
The Investment Case for Drugs That Serve Hundreds, Not Millions
 • Future Funds and Karl Rudolph
The Cracks Beneath the Private Credit Boom
This article is written by Meher
 • Future Funds and Meher
Surviving Through Healthcare AI: What the Hype Can Bring to Patients and Investors
This Article is written by Karl Rudolph
 • Future Funds and Karl Rudolph
Predicting Bond Spreads with Uncertainty Measures
Extending on Diebold and Li (2006)'s research
 • Future Funds and Chiel Evertz
Duolingo: A Game You Can’t Quit
A financial and strategic analysis of gamification, monetisation, and investment risk
 • Future Funds and Ruofan Pi
Why Stock Performance Doesn’t Tell the Whole Story: Is Novartis Nearing a Patent Cliff?
This article is written by Karl Rudolph
 • Future Funds and Karl Rudolph
Flow Traders: How a Market Maker Turns Volatility into Profit
Analysing ETP growth and the strategic implications of Flow Traders’ 2024 capital expansion plan
 • Future Funds and Ruofan Pi
Future Funds
Future Funds
The mission is clear, make our readers financially literate through weekly articles. Subscribe today to secure your future funds!
Recommendations
View all 18
The PIMM Trader · Investment Ideas to Grow Your Wealth
The PIMM Trader · Investment Ideas to Grow Your Wealth
Miguel A. Calles, MBA
DualEdge Invest
DualEdge Invest
DualEdge Invest
Schwar Capital Research
Schwar Capital Research
Schwar Capital Research
The Nasdaq Playbook
The Nasdaq Playbook
The NASDAQ Playbook
Cyclop SpaceTech
Cyclop SpaceTech
Matej Pretković
© 2026 Future Funds · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture
    This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts